T. Rowe Price Associates’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $309M | Buy |
8,046,392
+324,078
| +4% | +$12.4M | 0.04% | 344 |
|
|
2025
Q1 | $299M | Buy |
7,722,314
+155,392
| +2% | +$6.02M | 0.04% | 344 |
|
|
2024
Q4 | $256M | Buy |
7,566,922
+35,134
| +0.5% | +$1.19M | 0.03% | 377 |
|
|
2024
Q3 | $308M | Sell |
7,531,788
-2,700,488
| -26% | -$110M | 0.04% | 359 |
|
|
2024
Q2 | $394M | Sell |
10,232,276
-1,233,137
| -11% | -$47.5M | 0.05% | 309 |
|
|
2024
Q1 | $492M | Sell |
11,465,413
-1,353,545
| -11% | -$58M | 0.06% | 276 |
|
|
2023
Q4 | $475M | Buy |
12,818,958
+52,133
| +0.4% | +$1.93M | 0.06% | 266 |
|
|
2023
Q3 | $463M | Sell |
12,766,825
-265,296
| -2% | -$9.62M | 0.07% | 245 |
|
|
2023
Q2 | $464M | Buy |
13,032,121
+739,208
| +6% | +$26.3M | 0.06% | 260 |
|
|
2023
Q1 | $437M | Buy |
12,292,913
+673,419
| +6% | +$24M | 0.07% | 259 |
|
|
2022
Q4 | $408M | Buy |
11,619,494
+434,976
| +4% | +$15.3M | 0.07% | 263 |
|
|
2022
Q3 | $331M | Sell |
11,184,518
-3,659,199
| -25% | -$108M | 0.05% | 281 |
|
|
2022
Q2 | $646M | Sell |
14,843,717
-343,661
| -2% | -$15M | 0.08% | 238 |
|
|
2022
Q1 | $662M | Buy |
15,187,378
+67,179
| +0.4% | +$2.93M | 0.07% | 281 |
|
|
2021
Q4 | $667M | Buy |
15,120,199
+342,081
| +2% | +$15.1M | 0.06% | 299 |
|
|
2021
Q3 | $565M | Buy |
14,778,118
+109,503
| +0.7% | +$4.18M | 0.05% | 327 |
|
|
2021
Q2 | $584M | Sell |
14,668,615
-874,666
| -6% | -$34.8M | 0.05% | 313 |
|
|
2021
Q1 | $555M | Sell |
15,543,281
-1,008,836
| -6% | -$36M | 0.06% | 311 |
|
|
2020
Q4 | $609M | Sell |
16,552,117
-1,136,140
| -6% | -$41.8M | 0.06% | 294 |
|
|
2020
Q3 | $666M | Buy |
17,688,257
+64,824
| +0.4% | +$2.44M | 0.08% | 261 |
|
|
2020
Q2 | $719M | Buy |
17,623,433
+457,806
| +3% | +$18.7M | 0.09% | 231 |
|
|
2020
Q1 | $650M | Buy |
17,165,627
+1,916,168
| +13% | +$72.6M | 0.1% | 210 |
|
|
2019
Q4 | $717M | Buy |
15,249,459
+5,665
| +0% | +$266K | 0.09% | 236 |
|
|
2019
Q3 | $651M | Buy |
15,243,794
+89,144
| +0.6% | +$3.8M | 0.09% | 231 |
|
|
2019
Q2 | $606M | Sell |
15,154,650
-1,704,389
| -10% | -$68.2M | 0.09% | 245 |
|
|
2019
Q1 | $705M | Sell |
16,859,039
-1,232,057
| -7% | -$51.5M | 0.1% | 207 |
|
|
2018
Q4 | $691M | Buy |
18,091,096
+1,733,245
| +11% | +$66.2M | 0.12% | 183 |
|
|
2018
Q3 | $657M | Sell |
16,357,851
-318,982
| -2% | -$12.8M | 0.1% | 219 |
|
|
2018
Q2 | $672M | Buy |
16,676,833
+215,524
| +1% | +$8.69M | 0.1% | 206 |
|
|
2018
Q1 | $643M | Sell |
16,461,309
-109,044
| -0.7% | -$4.26M | 0.1% | 209 |
|
|
2017
Q4 | $588M | Sell |
16,570,353
-137,910
| -0.8% | -$4.89M | 0.1% | 227 |
|
|
2017
Q3 | $678M | Buy |
16,708,263
+3,257,372
| +24% | +$132M | 0.12% | 187 |
|
|
2017
Q2 | $580M | Buy |
13,450,891
+2,772,334
| +26% | +$120M | 0.1% | 215 |
|
|
2017
Q1 | $450M | Buy |
10,678,557
+285,713
| +3% | +$12M | 0.08% | 255 |
|
|
2016
Q4 | $400M | Buy |
10,392,844
+2,305,316
| +29% | +$88.8M | 0.08% | 274 |
|
|
2016
Q3 | $349M | Buy |
8,087,528
+331,856
| +4% | +$14.3M | 0.07% | 283 |
|
|
2016
Q2 | $336M | Buy |
7,755,672
+810,807
| +12% | +$35.1M | 0.07% | 292 |
|
|
2016
Q1 | $282M | Sell |
6,944,865
-1,304,844
| -16% | -$52.9M | 0.06% | 323 |
|
|
2015
Q4 | $333M | Buy |
8,249,709
+184,174
| +2% | +$7.43M | 0.07% | 290 |
|
|
2015
Q3 | $310M | Buy |
8,065,535
+1,839,662
| +30% | +$70.7M | 0.07% | 303 |
|
|
2015
Q2 | $259M | Sell |
6,225,873
-2,558,885
| -29% | -$107M | 0.05% | 379 |
|
|
2015
Q1 | $405M | Buy |
8,784,758
+406,595
| +5% | +$18.8M | 0.08% | 276 |
|
|
2014
Q4 | $358M | Buy |
8,378,163
+50,470
| +0.6% | +$2.16M | 0.08% | 302 |
|
|
2014
Q3 | $383M | Sell |
8,327,693
-712,138
| -8% | -$32.7M | 0.08% | 275 |
|
|
2014
Q2 | $483M | Buy |
9,039,831
+42,103
| +0.5% | +$2.25M | 0.1% | 230 |
|
|
2014
Q1 | $481M | Buy |
8,997,728
+740,734
| +9% | +$39.6M | 0.11% | 231 |
|
|
2013
Q4 | $441M | Buy |
8,256,994
+1,322,183
| +19% | +$70.6M | 0.1% | 243 |
|
|
2013
Q3 | $348M | Sell |
6,934,811
-572,465
| -8% | -$28.7M | 0.09% | 273 |
|
|
2013
Q2 | $375M | Buy |
+7,507,276
| New | +$375M | 0.1% | 253 |
|